A Practical Approach, Second Edition=Ronald D. Ho.pdf

HUMAN STUDIES 83926. Haglund, B. and Cnattingius, S., Cigarette smoking as risk factor for sudden infant death syndrome:a population-based study, Amer. J. Pub. Health, 80, 29, 1990.27. Ericson, A., Eriksson, M., Källén, B., and Zetterström, R., Socio-economic variables and pregnancyoutcome. 2. Infant and child survival, Acta Paediatr. Scand., 79, 1009, 1990.28. Winbo, I.G.B., Serenius, F.H., and Källén, B.A.J., Lack of precision in neonatal death classificationsbased on the underlying cause of death stated on death certificates, Acta Paediatr., 87, 1167, 1998.29. Wigglesworth, J.S., Monitoring perinatal mortality. A pathophysiological approach, Lancet, 2, 684,1980.30. Winbo, I.G.B., Serenius, F.H., Dahlquist, G.G., and Källén, B., NICE, a new cause of death classificationfor stillbirths and neonatal deaths, Int. J. Epidemiol., 27, 499, 1998.31. Källén, B., A birth weight for gestational age standard based on data in the Swedish Medical BirthRegistry, 1985–1989, Europ. J. Epidemiol., 11, 601, 1993.32. Ericson, A., Eriksson, M., Källén, B., and Zetterström, R., Secular trends in the effect of socioeconomicfactors on birth weight and infant survival in Sweden, Scand. J. Soc. Med., 21, 10, 1993.33. Ericson, A., Gunnarskog, J., Källén, B., and Otterblad Olausson, P., A registry study of very lowbirthweight liveborn infants in Sweden, 1973–1988, Acta Obst. Gynecol. Scand., 71, 104, 1992.34. English, P.B. and Eskenazi, B., Reinterpreting the effects of maternal smoking on infant birthweightand perinatal mortality: a multivariate approach to birthweight standardizationm Int. J. Epidemiol.,21, 1097, 1992.35. Ericson, A., Eriksson, M., Källén, B., and Meirik, O., Birth weight distribution as an indicator ofenvironmental effects on fetal development, Scand. J. Soc. Med., 15, 11, 1987.36. Mulvihill, J.J., and Czeizel, A.A., 1983 view of sentinel phenotypes, Mutation Res., 123, 345, 1983.37. Källén, B., Knudsen, L.B., Mutchinick, O., Mastroiacovo, P., Lancaster, P., Castilla, E., and Robert,E., Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformationregistries. An international feasibility study, Int. J. Epidemiol., 22, 107, 1993.38. Kieler, H., Cnattingius, S., Haglund, B., Palmgren, J., and Axelsson, O., Sinistrality — a side effectof prenatal sonography: a comparative study of young men, Epidemiology, 47, 618, 2001.39. Feldman, R.G. and White, R.F., Lead neurotoxicity and disorders of learning, J. Child Neurol., 7,354, 1992.40. Harada, M., Congenital Minimata disease: intrauterine methylmercury poisoning, Teratology, 18, 285,1978.41. Sutcliffe, A.G., Dsouza, S.W., Cadman, J., Richards, B., McKinlay, I.A., and Lieberman, B., Minorcongenital anomalies, major congenital malformations and development in children conceived fromcryopreserved embryos, Human Reprod., 10, 3332, 1995.42. Ericson, A., Nugren, K.G., Otterblad Olausson, P., and Källén, B., Hospital care utilization of infantsborn after in vitro fertilization. Human Reprod., 17, 929, 2002.43. Forsberg, J.-G. and Källén, B., Pregnancy and delivery characteristics of women whose infants developchild cancer, APMIS, 98, 37, 1990.44. Needleman, H.L., Gunnoe, C.G., Leviton, A., Reed, R., Peresie, H., Maher, C., and Barrett, P., Deficitsin psychologic and classroom performance of children with elevated dentine lead levels, New Engl.J. Med., 300, 689, 1979.45. Oryszczyb, M.P., Godin, J., Annesi, I., Hellier, G., and Kauffman, F., In utero exposure to parentalsmoking. Cotinine measurements and cord blood IgE, J. Allergy Clin. Immunol., 87, 6, 1991.46. Martínez-Frías, M.L. and Rodrigues-Pinilla, E., Epidemiologic analysis of prenatal exposure to coughmedicines containing dextromethorphan: no evidence of human teratogenicity, Teratology, 63, 38,2001.47. Boneva, R.S., Moore, C.A., Botto, L., Wong, L.Y., and Erickson, J.D. Nausea during pregnancy andcongenital heart defects: a population-based case-control study, Am. J. Epidemiol., 149, 717, 1999.48. Heinonen, O.P., Slone, D., and Shapiro, S., Birth Defects and Drugs in Pregnancy, Publishing SciencesGroup, Inc., Littleton, MA, 1977.49. Källén, B., Use of omeprazole during pregnancy — no hazard demonstrated in 955 infants exposedduring pregnancy, Obst. Gynecol., 96, 63, 2000.50. Nielsen, G.L., Sorensen, H.T., Larsen, H., and Pedersen, L., Risk of adverse birth outcome andmiscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observationalstudy and case-control study, Brit. Med. J., 322, 266, 2001.© 2006 by Taylor & Francis Group, LLC